Correction
ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells
Paper Information
Record ID:
11135
Author(s):
Publication Date:
June 01, 2010
Retraction Date:
September 01, 2010
(15.2 years years ago)
Subjects:
Institutions:
- Veterans Affairs Medical Center, Wayne State University, Detroit, Michigan
- Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
- Graduate Program in Cancer Biology, School of Medicine, Wayne State University, Detroit, Michigan
- Department of Internal Medicine, Wayne State University, Detroit, Michigan
- Department of Pathology, Wayne State University, Detroit, Michigan
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Correction Details
Retraction Reasons:
Nature of Retraction:
Correction
Retraction Notice:
10.1158/1535-7163.MCT-10-0671Additional Notes:
Wayne State University investigated researcher Fazlul Sarkar
Citations (16)
16
Total Citations15
Post-Retraction(93.8%)
0
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
7
After 2+ years
5295
Days since retraction (latest)
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Mar 2025
5295 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Mar 2023
4566 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Mar 2020
3469 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Oct 2016
2234 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Jul 2015
1764 days after retraction
Paper citing EMT Phenotype is Induced by Increased Src Kinase A...
Unknown Authors
Unknown Journal
Published: Jun 2014
1391 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Aug 2013
1084 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Dec 2011
456 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Oct 2011
399 days after retraction
Paper citing Antitumor Activity of Epidermal Growth Factor Rece...
Unknown Authors
Unknown Journal
Published: Sep 2011
387 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Jul 2011
322 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Jun 2011
273 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Jun 2011
273 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Mar 2011
193 days after retraction
Paper citing Gemcitabine Sensitivity Can Be Induced in Pancreat...
Unknown Authors
Unknown Journal
Published: Dec 2010
104 days after retraction
Paper citing ErbB-Inhibitory Protein: A Modified Ectodomain of ...
Unknown Authors
Unknown Journal
Published: Sep 2010
Same day as retraction
Quick Stats
Total Citations:
16
Years Since Retraction:
15.2 years
Open Access:
Yes
Last Checked:
Never